Search
for
Sort by
Research 721–750 of 1000+
- Comparison of androgenic alopecia distribution among type 2 diabetes and healthy women in Isfahan city: a brief report
- Comparison of the Therapeutic Effect of 2% Topical Minoxidil with Rosemary Solution in the Treatment of Alopecia Areata on the Scalp
- 地域・国際レポート 「あいちトリエンナーレ2010」の実施とその成果検証(中間とりまとめ)について
- Metabolic disease with autoimmune phenomena: 2 cases of SLE-like disease in young children diagnosed with lysinuric protein intolerance
- Efficacy of a herbal drug and Minoxidil 2% solution for treating Telogen effluvium infection
- Συγκριτική μελέτη κόλλας ιστών οκτυλ-2-κυανοακρυλικής και ραμμάτων υπό τάση στην επούλωση τομών δέρματος επιμύων
- co-sponsored by the international society of hair restoration surgery: Live Surgery Workshop XI: Advancing the Industry of Hair Restoration. March 2–5, 2005 orlando
- Influence of dietary linoleic acid (18:2, n6) on the effects of hyperthyroidism in Mus musculus
- ISID1342 – Spatial transcriptome profiling reveals TGFβ-2 in hair follicle progenitor cells is a potential driver of androgenetic alopecia
- Clinical Efficacy of Oral Administration of Finasteride at a dose of 2.5mg/Day in Women with Female Pattern Hair Loss
- Comparison between “5% minoxidil plus 2% flutamide” solution vs. “5% minoxidil” solution in the treatment of androgenetic alopecia
- Crystal structure of Steroid 5-alpha-reductase 2 in complex with Finasteride
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- The human type I keratin gene family: Characterization of new hair follicle specific members and evaluation of the chromosome 17q21.2 gene domain
- Modulation of glucocorticoid action and the treatment of type-2 diabetes
- Characterization of the Human Hair Keratin–Associated Protein 2 (KRTAP2) Gene Family
- 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection
- Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
- Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2
- Hair Tourniquet Syndrome of the Toe: Report of 2 New Cases
- PSEUDOFOLLICULITIS BARBAE. 2. TREATMENT
- Immunologic and Autoimmune-Related Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Sebaceous gland abnormalities in fatty acyl CoA reductase 2 (Far2) null mice result in primary cicatricial alopecia
- Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model